The Patent Finder
US

Aurora Kinase Inhibitors for Inhibiting Mitotic Progression

US 9,765,076 In force
OverviewFamilyAssignmentsSources & methods

Term ends Nov 14, 2027 · High confidence

Filed Oct 15, 2014 as application 14/514,687 · Granted Sep 19, 2017
Base term, 20 years from filing
Today
20 years from filing
2007 2027
Clock starts
Nov 14, 2007
Term ends
Nov 14, 2027
Granted
Sep 19, 2017
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
28
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 2 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Nov 14, 2007, when application 11/985,277, the earliest non-provisional in its chain, was filed (this one was filed Oct 15, 2014)Nov 14, 2027High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderNov 14, 2027High confidence

This family

US 7,572,784In force
no later than Dec 2027
no later than Dec 2027
US 8,026,246In force
May 2029
May 2029
US 8,399,659Term ended
Sep 2026
Sep 2026
US 9,173,846In force
May 2030
May 2030
Application 13/217,659Abandoned
not computed
not computed
US 9,988,384In force
Nov 2027
Nov 2027
US 9,102,678Term ended
May 2025
May 2025
US 9,765,076this patent
Nov 2027
Nov 2027
8 of 28 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Aug 11, 2017
Reel 43273, frame 379
Claiborne, Christopher F.; Sells, Todd B.; Stroud, Stephen G.Millennium Pharmaceuticals, Inc.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited